3 ms·
Apparently the issue is the testing. You need to purchase a large quantity of pills from the original manufacturer to compare your new batch with and that was h
by andrewpi 11y ago
Apparently the issue is the testing. You need to purchase a large quantity of pills from the original manufacturer to compare your new batch with and that was hard to obtain.
- o_nate 11y agoAh, I see. It sounds to me like the issue is that there's not enough of a market to attract the interest of another company to get over the initial fixed costs to get the drug approved. Seems like a possible reform would be to streamline the approval process for generics to make this easier.